BioMarin Pharmaceutical
BMRN
#1907
Rank
ยฃ7.70 B
Marketcap
ยฃ40.08
Share price
-0.78%
Change (1 day)
-22.69%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ1.10 Billion

According to BioMarin Pharmaceutical's latest financial reports the company has ยฃ1.10 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioMarin Pharmaceutical - Cash on Hand chart (from 1999 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ0.90 B7.56%
2023-12-31ยฃ0.84 B-21.05%
2022-12-31ยฃ1.06 B42.13%
2021-12-31ยฃ0.75 B-3.9%
2020-12-31ยฃ0.78 B35.97%
2019-12-31ยฃ0.57 B-32.7%
2018-12-31ยฃ0.85 B-17.3%
2017-12-31ยฃ1.03 B61.39%
2016-12-31ยฃ0.63 B60.04%
2015-12-31ยฃ0.39 B-34.13%
2014-12-31ยฃ0.60 B27.61%
2013-12-31ยฃ0.47 B71.71%
2012-12-31ยฃ0.27 B120.73%
2011-12-31ยฃ0.12 B-29.31%
2010-12-31ยฃ0.17 B-4.44%
2009-12-31ยฃ0.18 B-51.35%
2008-12-31ยฃ0.38 B29.58%
2007-12-31ยฃ0.29 B99.89%
2006-12-31ยฃ0.14 B432.09%
2005-12-31ยฃ27.71 M8.99%
2004-12-31ยฃ25.42 M-77.96%
2003-12-31ยฃ0.11 B150.03%
2002-12-31ยฃ46.13 M-48.97%
2001-12-31ยฃ90.41 M235.69%
2000-12-31ยฃ26.93 M-30.9%
1999-12-31ยฃ38.98 M589.55%
1998-12-31ยฃ5.65 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Ultragenyx Pharmaceutical
RARE
ยฃ0.31 B-71.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
ยฃ22.23 M-98.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
ยฃ69.39 M-93.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ7.84 B 607.24%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
ยฃ0.19 B-82.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
ยฃ0.51 B-53.32%๐Ÿ‡บ๐Ÿ‡ธ USA